Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities
Abstract Calcium dysregulation often underlies pathologies associated with aging and age-associated neurodegenerative diseases. Cells express a unique pattern of Ca2+ channels and pumps geared to fulfill specific physiological requirements and there is a decline in the fidelity of these processes wi...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aab8f71534334401ab0fe2d1f969c108 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:aab8f71534334401ab0fe2d1f969c108 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:aab8f71534334401ab0fe2d1f969c1082021-12-02T16:35:11ZTargeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities10.1038/s41514-020-00048-12056-3973https://doaj.org/article/aab8f71534334401ab0fe2d1f969c1082020-08-01T00:00:00Zhttps://doi.org/10.1038/s41514-020-00048-1https://doaj.org/toc/2056-3973Abstract Calcium dysregulation often underlies pathologies associated with aging and age-associated neurodegenerative diseases. Cells express a unique pattern of Ca2+ channels and pumps geared to fulfill specific physiological requirements and there is a decline in the fidelity of these processes with age and age-associated diseases. J147 is an Alzheimer’s disease (AD) drug candidate that was identified using a phenotypic screening platform based upon age-related brain toxicities that are mediated by changes in calcium metabolism. The molecular target for J147 is the α-F1-ATP synthase (ATP5A). J147 has therapeutic efficacy in multiple mouse models of AD and accelerated aging and extends life span in flies. A bioinformatics analysis of gene expression in rapidly aging SAMP8 mice during the last quadrant of their life span shows that J147 has a significant effect on ion transport pathways that are changed with aging, making their expression look more like that of younger animals. The molecular basis of these changes was then investigated in cell culture neurotoxicity assays that were the primary screen in the development of J147. Here we show that J147 and its molecular target, ATP synthase, regulate the maintenance of store-operated calcium entry (SOCE) and cell death during acute neurotoxicity.Joshua GoldbergAntonio CurraisGamze AtesLing HuangMaxim ShokhirevPamela MaherDavid SchubertNature PortfolioarticleGeriatricsRC952-954.6ENnpj Aging and Mechanisms of Disease, Vol 6, Iss 1, Pp 1-9 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Geriatrics RC952-954.6 |
spellingShingle |
Geriatrics RC952-954.6 Joshua Goldberg Antonio Currais Gamze Ates Ling Huang Maxim Shokhirev Pamela Maher David Schubert Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities |
description |
Abstract Calcium dysregulation often underlies pathologies associated with aging and age-associated neurodegenerative diseases. Cells express a unique pattern of Ca2+ channels and pumps geared to fulfill specific physiological requirements and there is a decline in the fidelity of these processes with age and age-associated diseases. J147 is an Alzheimer’s disease (AD) drug candidate that was identified using a phenotypic screening platform based upon age-related brain toxicities that are mediated by changes in calcium metabolism. The molecular target for J147 is the α-F1-ATP synthase (ATP5A). J147 has therapeutic efficacy in multiple mouse models of AD and accelerated aging and extends life span in flies. A bioinformatics analysis of gene expression in rapidly aging SAMP8 mice during the last quadrant of their life span shows that J147 has a significant effect on ion transport pathways that are changed with aging, making their expression look more like that of younger animals. The molecular basis of these changes was then investigated in cell culture neurotoxicity assays that were the primary screen in the development of J147. Here we show that J147 and its molecular target, ATP synthase, regulate the maintenance of store-operated calcium entry (SOCE) and cell death during acute neurotoxicity. |
format |
article |
author |
Joshua Goldberg Antonio Currais Gamze Ates Ling Huang Maxim Shokhirev Pamela Maher David Schubert |
author_facet |
Joshua Goldberg Antonio Currais Gamze Ates Ling Huang Maxim Shokhirev Pamela Maher David Schubert |
author_sort |
Joshua Goldberg |
title |
Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities |
title_short |
Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities |
title_full |
Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities |
title_fullStr |
Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities |
title_full_unstemmed |
Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities |
title_sort |
targeting of intracellular ca2+ stores as a therapeutic strategy against age-related neurotoxicities |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/aab8f71534334401ab0fe2d1f969c108 |
work_keys_str_mv |
AT joshuagoldberg targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities AT antoniocurrais targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities AT gamzeates targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities AT linghuang targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities AT maximshokhirev targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities AT pamelamaher targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities AT davidschubert targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities |
_version_ |
1718383711556206592 |